Cancer clinical trials info from ASCO

This week is the big ASCO meeting (American Society of Clinical Oncology Annual Meeting).

Lots of clinical trial info and survival data is presented.

Lots of pharmacutical companies and their drugs will be mentioned.

So far, kidney cancer and lung cancer drugs have been discussed in the news this weekend.

For ladies on this board:
phase 2 endo ca news regarding a nTOR inhibitor as well as promising phase 1 news for breast and ovarian cancer.
are in the news this morning.

Granted phase 1 and phase 2 aren't a phase 3 but they are a start toward possibly better treatments. If other treatments haven't worked, maybe these would be something to discuss with your doctor.

If you're interested, do a websearch for ASCO. Lots of stock market websites are covering it, as is CNBC this week.

Thanks for posting this Kate... you are the information guru around here. lol Seriously, you always take the time and energy to pass along what you believe could be important and valuable info...... and it is 'very' appreciated by many of us.

Diane ( baylee6)